Risk of hepatocellular carcinoma (HCC) recurrence in HCV cirrhotic patients treated with Direct Acting Antivirals (DAAs)

Risk of hepatocellular carcinoma (HCC) recurrence in HCV cirrhotic patients treated with Direct Acting Antivirals (DAAs)

Saved in:
Bibliographic Details
Published in:Digestive and liver disease Vol. 49; no. 1; p. e59
Main Authors: Cabibbo, G, Cacciola, I, Cannavò, M.R, Madonia, S, Calvaruso, V, Petta, S, Distefano, M, Larocca, L, Prestileo, T, Tinè, F, Digiacomo, A, Bertino, G, Giannitrapani, L, Benanti, F, Davì, A, Volpes, R, Scalisi, I, Iacobello, C, Mazzola, G, Cartabellotta, F, Guarneri, L, Portelli, V, Averna, A, Russello, M, Scifo, G, Squadrito, G, Raimondo, G, Craxì, A, Di Marco, V, Cammà, C
Format: Journal Article
Language:English
Published: Elsevier Ltd 16-02-2017
Subjects:
Gastroenterology and Hepatology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1590-8658
1878-3562
DOI:10.1016/j.dld.2017.01.119